Won Ki Kang - Researcher Profile | RDL Research Database

Publications

3 shown

Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer

Seung Tae Kim , Răzvan Cristescu , Adam J. Bass +20 more

Clinical studies support the efficacy of programmed cell death 1 (PD-1) targeted therapy in a subset of patients with metastatic gastric cancer (mGC). With the goal of identifyi...

2018 Nature Medicine 1624 citations

Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial

Yoon‐Koo Kang , Won Ki Kang , D.B. Shin +12 more

2009 Annals of Oncology 766 citations

High-Throughput Mutation Profiling Identifies Frequent Somatic Mutations in Advanced Gastric Adenocarcinoma

Jeeyun Lee , Paul Van Hummelen , Christina Go +8 more

Using high throughput mutation screening platform, we identified that PIK3CA mutations were the most frequently observed target for gastric adenocarcinoma.

2012 PLoS ONE 77 citations

Frequent Co-Authors

Researcher Info

h-index: 3
Publications: 3
Citations: 2,467
Institution: Samsung Medical Center

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0002-0049-8086

Impact Metrics

h-index 3

h-index: Number of publications with at least h citations each.